PRAX Q4 2023 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$515,000

Gross Profit

-$18M-3470.5% margin

Operating Income

-$28M-5399.2% margin

Net Income

-$27M-5219.0% margin

EPS (Diluted)

$-2.97

QoQ Revenue Growth

+10.0%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$88M

Total Liabilities

$18M

Stockholders' Equity

$70M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$515,000	$0	—
Gross Profit	-$18M	-$28M	+35.5%
Operating Income	-$28M	-$41M	+32.9%
Net Income	-$27M	-$41M	+34.7%

Revenue Segments

License

$400,000100%